Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Starts Life Sciences Philanthropic Organization

NEW YORK (GenomeWeb News) – Invitrogen is starting a philanthropic foundation that will support endeavors focused on increasing participation in and understanding of life sciences by students, teachers, scientists, and the general public, the company said today.
 
The company said it has granted $1 million to get the foundation going and will provide further funding in the future.
 
Invitrogen CEO Greg Lucier said the Invitrogen Foundation will “focus on encouraging more students to embrace a career in the sciences, as well as celebrating the accomplishments of today’s researchers and the improvements their work brings to our lives everyday.” 
 
In addition to supporting specific programs through grants, the foundation intends to develop other resources including an educational website aimed at providing life sciences information to the public, CFO David Hoffmeister added.
 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.